Notable Labs

Notable Labs ROA

The Return on Assets (ROA) of Notable Labs (NTBLQ) as of Nov 11, 2026 is -57.64 %. In the previous year, Return on Assets (ROA) was -108.90 % — a change of -47.07% (higher).

ROA

-57.64 %

YoY

-47.07%

Last updated:

In 2023, Notable Labs's return on assets (ROA) was -57.64 %, a -47.07% increase from the -108.90 % ROA in the previous year.

The Notable Labs ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2016
-33.85 USD
Jan 1, 2017
-15.44 USD
Jan 1, 2018
-33.78 USD
Jan 1, 2019
-39.58 USD
Jan 1, 2020
-58.09 USD
Jan 1, 2021
-46.27 USD
Jan 1, 2022
-108.90 USD
Jan 1, 2023
-57.64 USD
The Notable Labs ROA history
YEARROAYoY
-57.64 %-47.07%
-108.90 %+135.35%
-46.27 %-20.35%
-58.09 %+46.76%
-39.58 %+17.17%
-33.78 %+118.86%
-15.44 %-54.40%
-33.85 %-10.80%
-37.95 %-16.87%
-45.65 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Notable Labs Stock analysis

What does Notable Labs do? Notable Labs Ltd, formerly Vascular Biogenics Ltd, is an Israel-based clinical-stage biopharmaceutical company developing targeted medicines for cancer and immune-inflammatory diseases. The company leverages two platform technologies: Vascular Targeting System (VTS), a gene-based approach targeting newly formed blood vessels, and Monocyte Targeting Technology (MTT), an antibody-based method inhibiting monocyte migration. Its product candidates aim to improve patient outcomes by overcoming limitations of current treatments. The firm's pipeline focuses on difficult-to-treat conditions, with VTS and MTT serving as the core technologies for developing therapeutics. VTS targets cancer by focusing on blood vessel formation, while MTT addresses immune-inflammatory diseases through monocyte migration control. These technologies enable the creation of next-generation medicines that address unmet medical needs. Notable Labs Ltd sells its product candidates to pharmaceutical companies and healthcare providers for further development and clinical trials. The primary buyers are biopharmaceutical firms seeking innovative therapies, particularly those targeting cancer and immune-inflammatory conditions. The company's revenue model relies on licensing agreements and partnerships with these industry players to advance its pipeline. Notable Labs is one of the most popular companies on Eulerpool.

ROA Details

Understanding Notable Labs's Return on Assets (ROA)

Notable Labs's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Notable Labs's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Notable Labs's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Notable Labs’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Notable Labs stock

Return on Assets (ROA) of Notable Labs is -57.64 % in 2023.

Return on Assets (ROA) of Notable Labs changed from -108.90 % to -57.64 %, representing a -47.07% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Notable Labs since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Notable Labs with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Notable Labs

All Key Metrics — Notable Labs